Allocations
Francisco Partners has held the closing of Francisco Partners V (FP V), a USD3.975 billion fund that will continue the firm’s history of partnering with management teams and investing in companies across the technology ecosystem.
Francisco Partners closed its largest fund to date in less than six months through a significantly oversubscribed process. The firm has now raised over USD14 billion in committed capital since its inception 18 years ago.
Dipanjan “DJ” Deb, co-founder & CEO of Francisco Partners, says: “We appreciate the overwhelming support we received from our limited partners and are excited to welcome a select group of new
Inflexion Private Equity has backed the management buyout of PCMS Group, a provider of point-of-sale (POS) software for major retailers such as Walgreens, John Lewis and Arcadia Group.
PCMS offers an integrated unified commerce platform for retail selling points for in-store (POS, self-checkout, self-scan) or cloud-hosted environments (eCommerce, mobile). This software is paramount in the digital retail environment creating a seamless shopping experience for customers regardless of their location and facilitating ‘on-the-go’ retail transactions. The business has over 450 employees in the UK, US and Singapore with over 140 blue-chip customers in 55 countries.
PCMS has delivered reliability and
VeggieLand, a client of investment bank Tully & Holland, has been acquired by Nature’s Soy, a portfolio company of Chicago-based Keystone Capital.
VeggieLand, based in Parsippany New Jersey, was an independently owned, broadly known brand name in the meatless industry with brands such as Franklin Farms and Jens and Marie under its portfolio. The Company handles a broad mix of private label, food service and retail business. With its superior products, clean labels, healthy on-trend product line, diversified customer base and distribution channels, solid financial performance and additional growth potential, VeggieLand was an attractive candidate for several strategic and financial
Dallas based Surge Private Equity has completed its investment in Manhattan based Busy Bee Cleaning Corp, a commercial janitorial services provider, and sister companies Commercial Cleaning Services and Janitorial Cleaning Services.
The investment closed with debt financing provided by Harvest Capital Credit Corporation.
Busy Bee is a commercial janitorial services company boasting over: 1,000 customers, 200 employees, and a decade of high quality service to local and national businesses. Founders Greg and Fatima Wiszniewski will be staying on in their current capacities as CEO and COO. Both will retain equity in the business. Greg Wiszniewski will serve on the
GRI Club is the latest member to join the Climate Bonds Partner Program with the objective to boost infrastructure investment across emerging markets.
GRI is a global organisation that brings together key actors across two critical economic and industry sectors – real estate and infrastructure.
Since 2015 GRI Club has been committed to promoting business opportunities and connections between investors, developers, banks, utilities and infrastructure managers.
With the growing investor demand for green infrastructure, buildings and clean energy, CBI and GRI will work together to unlock green bond markets across emerging economies and open up new sources of
YO! Sushi (YO!) has acquired Bento Sushi (Bento), North America’s second largest sushi brand, creating a global multi-channel and multi-brand sushi platform.
The acquisition values Bento at CAD100 million and has been facilitated by Mayfair Equity Partners, who partnered with the YO! management team as part of a management buyout in 2015.
Bento, founded in Toronto in 1996 by Ken Valvur, is the second largest sushi brand in North America, and the largest in Canada trading from over 600 locations, whilst supplying sushi to a further 1700 partner sites. Bento operates across a range of formats which complement YO!’s
Quinbrook Infrastructure Partners (Quinbrook), a global investment manager specialising in lower carbon and renewable energy infrastructure, has acquired an 84 Megawatt (MW) gas-fired power project portfolio located across 4 sites in England and Wales.
Quinbrook plans to invest over USD60 million to acquire and construct the projects, which will become revenue-generating over the next twelve months. This latest investment marks the founders’ return to the United Kingdom’s clean energy infrastructure market and is the maiden investment in Quinbrook’s UK low carbon power platform.
Quinbrook acquired 100 per cent of the fully permitted and construction-ready 84 MW Eider Reserve Power
Following its acquisition by PraxisIFM Group last month, Kompas International has agreed to acquire 100 per cent of the issued share capital of Private Equity Services (PES), subject to normal completion conditions and regulatory approvals.
The acquisition is in line with the Group’s plans to grow its corporate and private client services further, both in reach and people.
Commercial director of Kompas Guido Wagenaar says: “The acquisition of PES is a great step in strengthening our team in The Netherlands as a hub for PraxisIFM’s services on Europe’s mainland” said Mr Wagenaar. “PES has very knowledgeable, experienced people whom
Specialist investment advisory firm Gravis Advisory Limited is to launch the VT Gravis Clean Energy Income Fund on Friday 1 December.
Gravis anticipates the Fund will provide investors with an attractive and regular income stream expected to deliver a yield of 4.5 per cent per annum from launch, paid quarterly and net of charges which are capped at 0.8 per cent. The Fund will also seek to preserve and grow capital over time by investing in a diversified portfolio of listed securities whose operations are linked to the theme of clean energy generation.
The core holdings of the Fund
Gide has advised Erytech Pharma, a company listed on Euronext Paris, on its initial public offering on the Nasdaq Global Select Market, through a reserved capital increase to American and European specialist investors for a total aggregate amount of USD144 million, after full exercise of the over-allotment option.
Erytech is a French clinical-stage biopharmaceutical company developing innovative therapies by encapsulating therapeutic drug substances inside red blood cells. The funds raised will in particular enable the company to conduct its Phase 3 studies for the treatment of second-line pancreatic cancer and the treatment of first-line acute lymphoblastic leukemia.
This transaction
Events
12 November, 2026 – 8:00 am
12 November, 2026 – 5:00 pm
